<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">K. Hoebe</style></author><author><style face="normal" font="default" size="100%">Z. Jiang</style></author><author><style face="normal" font="default" size="100%">P. Georgel</style></author><author><style face="normal" font="default" size="100%">K. Tabeta</style></author><author><style face="normal" font="default" size="100%">E. Janssen</style></author><author><style face="normal" font="default" size="100%">X. Du</style></author><author><style face="normal" font="default" size="100%">Bruce Beutler</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">TLR signaling pathways: Opportunities for activation and blockade in pursuit of therapy</style></title><secondary-title><style face="normal" font="default" size="100%">Current Pharmaceutical Design</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2006</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/17100615</style></url></web-urls></urls><pages><style face="normal" font="default" size="100%">4123-4134</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">32</style></issue><custom7><style face="normal" font="default" size="100%">000242002100003</style></custom7></record></records></xml>